Trastuzumab therapy suppresses HER2+breast tumor growth through inducing ADCP by tumor-associated macrophages and synergizes with CD47 checkpoint blockade.
Publication
, Conference
Tsao, L-C; Lyerly, HK; Hartman, Z
Published in: Cancer Immunology Research
April 1, 2020
Duke Scholars
Published In
Cancer Immunology Research
EISSN
2326-6074
ISSN
2326-6066
Publication Date
April 1, 2020
Volume
8
Issue
4
Start / End Page
84 / 84
Publisher
AMER ASSOC CANCER RESEARCH
Related Subject Headings
- 1115 Pharmacology and Pharmaceutical Sciences
- 1112 Oncology and Carcinogenesis
- 1107 Immunology
Citation
APA
Chicago
ICMJE
MLA
NLM
Tsao, L.-C., Lyerly, H. K., & Hartman, Z. (2020). Trastuzumab therapy suppresses HER2+breast tumor growth through inducing ADCP by tumor-associated macrophages and synergizes with CD47 checkpoint blockade. In Cancer Immunology Research (Vol. 8, pp. 84–84). AMER ASSOC CANCER RESEARCH.
Tsao, Li-Chung, Herbert Kim Lyerly, and Zachary Hartman. “Trastuzumab therapy suppresses HER2+breast tumor growth through inducing ADCP by tumor-associated macrophages and synergizes with CD47 checkpoint blockade.” In Cancer Immunology Research, 8:84–84. AMER ASSOC CANCER RESEARCH, 2020.
Tsao L-C, Lyerly HK, Hartman Z. Trastuzumab therapy suppresses HER2+breast tumor growth through inducing ADCP by tumor-associated macrophages and synergizes with CD47 checkpoint blockade. In: Cancer Immunology Research. AMER ASSOC CANCER RESEARCH; 2020. p. 84–84.
Tsao, Li-Chung, et al. “Trastuzumab therapy suppresses HER2+breast tumor growth through inducing ADCP by tumor-associated macrophages and synergizes with CD47 checkpoint blockade.” Cancer Immunology Research, vol. 8, no. 4, AMER ASSOC CANCER RESEARCH, 2020, pp. 84–84.
Tsao L-C, Lyerly HK, Hartman Z. Trastuzumab therapy suppresses HER2+breast tumor growth through inducing ADCP by tumor-associated macrophages and synergizes with CD47 checkpoint blockade. Cancer Immunology Research. AMER ASSOC CANCER RESEARCH; 2020. p. 84–84.
Published In
Cancer Immunology Research
EISSN
2326-6074
ISSN
2326-6066
Publication Date
April 1, 2020
Volume
8
Issue
4
Start / End Page
84 / 84
Publisher
AMER ASSOC CANCER RESEARCH
Related Subject Headings
- 1115 Pharmacology and Pharmaceutical Sciences
- 1112 Oncology and Carcinogenesis
- 1107 Immunology